SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 70.47 |
Enterprise Value ($M) | 68.09 |
Book Value ($M) | 18.89 |
Book Value / Share | 0.59 |
Price / Book | 3.73 |
NCAV ($M) | 18.66 |
NCAV / Share | 0.58 |
Price / NCAV | 3.78 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.66 |
Return on Assets (ROA) | -0.49 |
Return on Equity (ROE) | -0.54 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.54 |
Current Ratio | 8.54 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 21.36 |
Assets | 21.59 |
Liabilities | 2.70 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -13.83 |
Net Income | -12.55 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -7.33 |
Cash from Investing | 4.28 |
Cash from Financing | 3.42 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Catelani Michael | 5.25 | ||
13D/A | Kumar Amit | 13.50 | 42.70 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
24,526 | 126,324 | 19.42 | |
3,285 | 41,859 | 7.85 | |
3,234 | 45,411 | 7.12 | |
(click for more detail) |
Similar Companies | |
---|---|
ALVR – AlloVir, Inc. | ALZN – Alzamend Neuro, Inc. |
ANEB – Anebulo Pharmaceuticals, Inc. | APM – Aptorum Group Limited |
APRE – Aprea Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io